Home ยป “Heterogeneity and Incomplete Reporting in Studies of PD-1/PD-L1 Inhibitors in NSCLC Patients with Rare Genetic Alterations: Call for More Prospective Studies”

“Heterogeneity and Incomplete Reporting in Studies of PD-1/PD-L1 Inhibitors in NSCLC Patients with Rare Genetic Alterations: Call for More Prospective Studies”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38112201

A literature review shows heterogeneity and lack of reporting on important factors in studies examining the efficacy of PD-1/PD-L1 inhibitors in advanced or metastatic NSCLC patients with less common genetic alterations, indicating a need for further prospective studies.

You may also like

Leave a Comment